Skip to main content
SpineGuard logo

SpineGuard — Investor Relations & Filings

Ticker · ALSGD ISIN · FR0011464452 LEI · 969500Z4BRXQX6CSL565 PA Manufacturing
Open in API
Filings indexed 466 across all filing types
Latest filing 2023-11-15 Capital/Financing Update
Country FR France
Listing PA ALSGD

About SpineGuard

https://www.spineguard.com/

SpineGuard is a medical technology company that develops and markets the proprietary Dynamic Surgical Guidance (DSG) technology. DSG is a radiation-free, real-time sensing platform designed to make spine surgery safer. The technology is embedded in the company's PediGuard family of smart drilling instruments, which assist surgeons in the accurate placement of skeletal implants, particularly pedicle screws. By differentiating tissue types at the instrument's tip, the devices provide audible and visual feedback to help anticipate potential breaches of the vertebral wall, thereby enhancing procedural safety and accuracy. SpineGuard's primary goal is to establish DSG as a standard of care for securing and streamlining skeletal implant placement.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...)
Capital/Financing Update Classification · 99% confidence The document is a press release dated November 15, 2023, announcing the launch of a capital increase ('augmentation de capital') with preferential subscription rights ('maintien du droit préférentiel de souscription des actionnaires'). It details the subscription price (€0.20 per share), parity (1 new share for 4 existing shares), subscription periods, and the intended use of the proceeds (financing commercial efforts in the US and accelerating new product launches). This content directly relates to fundraising, financing activities, and capital structure changes. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (over 4,500 characters), indicating it is the primary announcement/report, not just a brief RPA.
2023-11-15 French
Inside Information / News release on accounts, results
Earnings Release Classification · 100% confidence The document is titled "SpineGuard announces its Q3 2023 revenue" and provides unaudited revenue figures for the first nine months of 2023, broken down by quarter (Q1, Q2, Q3). It includes commentary on business performance and cash position, which are hallmarks of a periodic financial results announcement. This content aligns perfectly with the definition of an Earnings Release (ER), which is the initial announcement of periodical financial results (key highlights only). Although it contains some forward-looking statements and financing mentions, the primary focus is the quarterly revenue announcement. Q3 2023
2023-10-11 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document is titled "SpineGuard annonce son chiffre d'affaires du 3 ème trimestre 2023" (SpineGuard announces its revenue for the third quarter of 2023). It explicitly details quarterly revenue figures (€ thousands, unaudited) for Q1, Q2, and Q3 2023 compared to 2022, and provides management commentary on the results and outlook. This content structure—a press release focused on periodic financial performance highlights for a period shorter than a full year (Q3)—is characteristic of an Earnings Release (ER). It is not a comprehensive annual report (10-K) or a detailed interim report (IR), but rather the initial announcement of the period's results. Q3 2023
2023-10-11 French
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 100% confidence The document is a press release dated September 18, 2023, announcing that researchers presented a scientific paper on SpineGuard's DSG technology applied to robotics at the CRAS conference. It details the positive results (100% success rate) of an *ex vivo* experiment and includes quotes from management, researchers, and a professor. This format—a formal announcement detailing recent scientific/research progress, often referencing a presentation or publication—is characteristic of an Investor Presentation (IP) or a general press release about scientific findings. Since it is a detailed announcement about research progress and its implications, and not a formal regulatory filing (like 10-K or IR) or a transcript of a call, 'Investor Presentation' (IP) is the closest fit, as these often contain detailed technical/strategic updates aimed at investors, even if the immediate trigger was a conference presentation. It is not a short announcement of a report (RPA/RNS), as the content is substantial and descriptive of the findings themselves.
2023-09-18 French
Inside Information / Other news releases
Regulatory Filings Classification · 99% confidence The document is a press release dated September 18th, 2023, announcing that results related to SpineGuard's DSG® technology applied to robotics were presented at the CRAS conference. It details scientific findings, quotes key personnel (CEO, Research Director, Professor), and includes standard company/contact information and a disclaimer. This format—announcing scientific progress or presentation of research findings rather than releasing periodic financial results (ER/IR) or providing a full transcript (CT)—is characteristic of a general corporate update or announcement. Since it is not a formal regulatory filing like a 10-K, nor a specific financial report, and it focuses on scientific/technological validation, it best fits the general 'Regulatory Filings' (RNS) category as a broad corporate announcement, or potentially an Investor Presentation (IP) if it were the presentation itself, but here it is an announcement *about* a presentation. Given the options, RNS serves as the best fit for a non-standard, non-financial, non-governance corporate announcement.
2023-09-18 English
Informations privilégiées / Communiqué sur comptes, résultats
Earnings Release Classification · 100% confidence The document is titled "SpineGuard publie ses résultats du premier semestre 2023" (SpineGuard publishes its first-half 2023 results). It contains detailed financial tables (Chiffre d'affaires, Résultat net, EBITDA) for H1 2023 compared to H1 2022, prepared according to IFRS standards, and discusses key financial elements and operational highlights for the six-month period ending June 30, 2023. This structure and content strongly indicate a comprehensive financial report for an interim period shorter than a year. This aligns perfectly with the definition of an Interim / Quarterly Report (Code: IR). Although it mentions the full report is available on the website, the text provided *is* the substance of the results announcement, not just a notice of publication (RPA). H1 2023
2023-09-12 French

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.